{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:27:18Z","timestamp":1759991238242,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.jinf.2004.11.004","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T10:46:35Z","timestamp":1103885195000},"page":"201-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae"],"prefix":"10.1016","volume":"51","author":[{"given":"Dirkie","family":"van Rensburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Fogarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cristina","family":"De Salvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manickam","family":"Rangaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roomi","family":"Nusrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2004.11.004_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.11.004_bib2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community-acquired pneumonia in the era of pneumococcal resistance. A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2004.11.004_bib3","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl. IV","key":"10.1016\/j.jinf.2004.11.004_bib4","first-page":"1","article-title":"BTS guidelines for the management of community-acquired pneumonia in adults","volume":"56","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jinf.2004.11.004_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.jinf.2004.11.004_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1469-0691.8.s.2.5.x","article-title":"Surveillance of resistance in bacteria causing community-acquired respiratory tract infections","volume":"8","author":"Felmingham","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2004.11.004_bib7","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.286.15.1857","article-title":"Macrolide resistance among invasive Streptococcus pneumoniae isolates","volume":"286","author":"Hyde","year":"2001","journal-title":"JAMA"},{"year":"2001","series-title":"Worldwide surveillance of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes: results from PROTEKT (1999\u20132000)","author":"Reinert","key":"10.1016\/j.jinf.2004.11.004_bib8"},{"key":"10.1016\/j.jinf.2004.11.004_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00006454-199611000-00026","article-title":"Breakthrough sepsis in macrolide-resistant pneumococcal infection","volume":"15","author":"Jackson","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2004.11.004_bib10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/318157","article-title":"Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin","volume":"31","author":"Kelley","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.11.004_bib11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.11.004_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/jac\/dkg116","article-title":"Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams","volume":"51","author":"Van Kerkhoven","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2004.11.004_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"For the Canadian bacterial surveillance network. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.11.004_bib14","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.11.004_bib15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1742-1241.2003.tb10543.x","article-title":"Telithromycin: the first ketolide antibacterial for the treatment of community-acquired infections","volume":"57","author":"Lorenz","year":"2003","journal-title":"Int J Clin Pract"},{"year":"2001","series-title":"Efficacy of the first ketolide antibacterial, telithromycin, in the treatment of adult patients with community-acquired pneumonia caused by Streptococcus pneumoniae","author":"Fogarty","key":"10.1016\/j.jinf.2004.11.004_bib16"},{"key":"10.1016\/j.jinf.2004.11.004_bib17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s15010-002-2096-z","article-title":"Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia","volume":"30","author":"Hagberg","year":"2002","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2004.11.004_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1185\/030079902125001191","article-title":"Efficacy and safety of telithromycin in community-acquired pneumonia","volume":"18","author":"van Rensburg","year":"2002","journal-title":"Curr Opin Med Res"},{"key":"10.1016\/j.jinf.2004.11.004_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1742-1241.2003.tb10511.x","article-title":"Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults","volume":"57","author":"Pullman","year":"2003","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jinf.2004.11.004_bib20","unstructured":"Tellier G, Isakov T, Peterman W, Patel M, Lavin B. Efficacy and safety of telithromycin (800mg once daily) for 5 or 7 days vs clarithromycin (500mg twice daily) for 10 days in the treatment of patients with community-acquired pneumonia. Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, USA [Abstract L-373]."},{"key":"10.1016\/j.jinf.2004.11.004_bib21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1469-0691.2003.00678.x","article-title":"Efficacy of telithromycin, a new once-daily ketolide antimicrobial, in the treatment of community-acquired pneumonia","volume":"9","author":"Carbon","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2004.11.004_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0149-2918(04)90005-7","article-title":"Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults","volume":"26","author":"Dunbar","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jinf.2004.11.004_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.11.004_bib24","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s15010-003-3142-1","article-title":"A pooled analysis of telithromycin in the treatment of community-acquired respiratory tract infections in adults","volume":"31","author":"Carbon","year":"2003","journal-title":"Infection"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445304002580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445304002580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:28:22Z","timestamp":1758986902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445304002580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0163445304002580"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2004.11.004","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2005,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2004.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}